Azitra, Inc.
AZTR- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001701478
No open-market purchases or sales by Azitra, Inc. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Azitra, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 4 | 8 | +4 |
| Shares | 136.2K | 182.3K | +46.1K (+33.9%) |
| Value | $495.6K | $273.4K | −$222.2K (−44.8%) |
New holders (4)
Institutions that held Azitra, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 22,427 | $33.6K | 0.00% |
| BlackRock Inc. | 4,209 | $6.31K | 0.00% |
| UBS Group AG | 145 | $218 | 0.00% |
| Wells Fargo & Company | 11 | $17 | 0.00% |
Sold out (0)
Institutions that held Azitra, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
None.